• No need to change gloves to enter MIS data—with CDX, dialysis treatment and
    MIS data are input in one contained environment.
  • Machine, foldable QWERTY keyboard and mouse pad are fully compliant with
    CDC surface disinfection guidelines.
  • Risk of cross-contamination and CMS V-tag citations reduced.
 
  • Simplify multidisciplinary care planning through immediate MIS access chairside.
  • Immediate, comprehensive access to intradialytic and trending information.
  • Treatment specific task lists help to ensure accurate prescription, lab order and
    medication administration.
  • Immediate electronic chair side documentation helps to eliminate loss of valuable
    medical and claim submission information.
  • Station set up and maintenance are easier with no computer cart or cables in the way.
 
  • Streamlined design—MIS and dialysis machine in one. No more computers-on-wheels.
  • Eliminates the loss of valuable treatment space allocated to MIS systems and carts.
  • Removes unsightly cables and other impediments which may reduce employee and
    patient risks associated with clutter in the treatment area.
 


Fresenius Logo

Caution: Federal (US) law restricts these devices to sale by or on the order of a physician.

Note: Read the Instructions for Use for safe and proper use of these devices. For a complete description of hazards, contraindications, side effects and precautions, see full package labeling at www.fmcna.com.

This site is intended for visitors from the United States.

© 2013-2017, Fresenius Medical Care, All Rights Reserved. Fresenius Medical Care, the triangle logo, Fresenius Renal Technologies, 2008, bibag, DIASAFE, Fresenius Polysulfone, Twister, Crit-Line, CLiC, and Clinical Data eXchange (CDX) are trademarks of Fresenius Medical Care Holdings, Inc., or its affiliated companies. Citrasate is a registered trademark of Advanced Renal Technologies in the United States and is used under license from Advanced Renal Technologies. All other trademarks are the property of their respective owners. P/N 102054-01 Rev C 10/2017